BIIB
$319.26
Biogen
$.18
.06%
Earnings Details
3rd Quarter September 2018
Tweet Share Watch
Summary

Biogen Beats

Biogen (BIIB) reported 3rd Quarter September 2018 earnings of $7.40 per share on revenue of $3.4 billion. The consensus earnings estimate was $6.80 per share on revenue of $3.3 billion. The Earnings Whisper number was $6.91 per share. Revenue grew 11.7% on a year-over-year basis.

Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.

Results
Reported Earnings
$7.40
Earnings Whisper
$6.91
Consensus Estimate
$6.80
Reported Revenue
$3.44 Bil
Revenue Estimate
$3.33 Bil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release